Literature DB >> 12695569

Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering.

Lara Myers1, Chikara Takahashi, Robert S Mittler, Robert J Rossi, Anthony T Vella.   

Abstract

To better understand how innate and adaptive immune responses interact with each other, we combined 4-1BB T cell costimulation with specific adjuvants to determine whether these treatments would influence specific T cell expansion and function in vivo. In the presence of 4-1BB ligation and Toll-like receptor 3 (TLR)3 and/or TLR4 triggering, CD8 T cell clonal expansion and survival was augmented profoundly. Specific T cells primed in vivo with TLR ligands responded normally to in vitro recall stimulus, but, surprisingly, copriming with 4-1BB costimulation significantly impaired the recall response even though many more specific effector T cells were rescued in vivo. Here, we demonstrate that the rescued CD8 T cells suppressed CD4 T cell proliferation via a type beta transforming growth factor-dependent mechanism. Thus, 4-1BB and TLR ligands induce survival of specific effector CD8 T cells with suppressive recall potential, which may explain the dual role that 4-1BB activation plays in mediating tumor clearance and prevention of autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695569      PMCID: PMC154348          DOI: 10.1073/pnas.0837611100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Induction of bystander T cell proliferation by viruses and type I interferon in vivo.

Authors:  D F Tough; P Borrow; J Sprent
Journal:  Science       Date:  1996-06-28       Impact factor: 47.728

2.  Clonal expansion precedes anergy and death of V beta 8+ peripheral T cells responding to staphylococcal enterotoxin B in vivo.

Authors:  H R MacDonald; S Baschieri; R K Lees
Journal:  Eur J Immunol       Date:  1991-08       Impact factor: 5.532

3.  Inducible T cell antigen 4-1BB. Analysis of expression and function.

Authors:  K E Pollok; Y J Kim; Z Zhou; J Hurtado; K K Kim; R T Pickard; B S Kwon
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

4.  Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity.

Authors:  S Webb; C Morris; J Sprent
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

5.  The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens.

Authors:  A M Pullen; P Marrack; J W Kappler
Journal:  Nature       Date:  1988-10-27       Impact factor: 49.962

6.  Identification of a monoclonal antibody specific for a murine T3 polypeptide.

Authors:  O Leo; M Foo; D H Sachs; L E Samelson; J A Bluestone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

7.  Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis.

Authors:  R S Liblau; R Tisch; K Shokat; X Yang; N Dumont; C C Goodnow; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

8.  Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen.

Authors:  J E McCormack; J E Callahan; J Kappler; P C Marrack
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

9.  Lipopolysaccharide interferes with the induction of peripheral T cell death.

Authors:  A T Vella; J E McCormack; P S Linsley; J W Kappler; P Marrack
Journal:  Immunity       Date:  1995-03       Impact factor: 31.745

10.  Turnover of naive- and memory-phenotype T cells.

Authors:  D F Tough; J Sprent
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  26 in total

1.  Study of relieving graft-versus-host disease by blocking CD137-CD137 ligand costimulatory pathway in vitro.

Authors:  Kailin Xu; Chaohong Li; Xiuying Pan; Bing Du
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

Review 2.  Costimulatory molecules as immunotherapeutic targets in systemic lupus erythematosus.

Authors:  Juergen Foell; Robert S Mittler
Journal:  Springer Semin Immunopathol       Date:  2006-09-02

Review 3.  Approaches to studying costimulation of human antiviral T cell responses: prospects for immunotherapeutic vaccines.

Authors:  Lena Serghides; Mariana Vidric; Tania H Watts
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice.

Authors:  Liguo Niu; Simona Strahotin; Becker Hewes; Benyue Zhang; Yuanyuan Zhang; David Archer; Trent Spencer; Dirck Dillehay; Byoung Kwon; Lieping Chen; Anthony T Vella; Robert S Mittler
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

Review 5.  TH2 cells in the pathogenesis of airway remodeling: regulatory T cells a plausible panacea for asthma.

Authors:  Halvor S McGee; Devendra K Agrawal
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 6.  CD137 and CD137L signals are main drivers of type 1, cell-mediated immune responses.

Authors:  Bhushan Dharmadhikari; Meihui Wu; Nur Sharalyn Abdullah; Sakthi Rajendran; Nur Diana Ishak; Emily Nickles; Zulkarnain Harfuddin; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2015-11-11       Impact factor: 8.110

Review 7.  Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapy.

Authors:  Adam J Adler; Payal Mittal; Joseph M Ryan; Beiyan Zhou; Jeffrey S Wasser; Anthony T Vella
Journal:  Immunotherapy       Date:  2017-01       Impact factor: 4.196

8.  4-1BB signaling synergizes with programmed death ligand 1 blockade to augment CD8 T cell responses during chronic viral infection.

Authors:  Vaiva Vezys; Pablo Penaloza-MacMaster; Daniel L Barber; Sang-Jun Ha; Bogumila Konieczny; Gordon J Freeman; Robert S Mittler; Rafi Ahmed
Journal:  J Immunol       Date:  2011-07-08       Impact factor: 5.422

9.  IFN-gamma-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivo.

Authors:  Young H Kim; Beom K Choi; Woo J Kang; Kwang H Kim; Sang W Kang; Andrew L Mellor; David H Munn; Byoung S Kwon
Journal:  J Leukoc Biol       Date:  2009-02-13       Impact factor: 4.962

10.  Adjuvantive effects of anti-4-1BB agonist Ab and 4-1BBL DNA for a HIV-1 Gag DNA vaccine: different effects on cellular and humoral immunity.

Authors:  Sumita Ganguly; Jinyan Liu; Vinod B Pillai; Robert S Mittler; Rama Rao Amara
Journal:  Vaccine       Date:  2009-11-26       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.